A new CMS policy on Medicare Part D plans' formularies may mean less prescription-related paperwork for physicians -- at least for the rest of 2006. The policy requires Part D plans to continue covering medications for Medicare enrollees, even if the companies drop the drugs from their formularies.
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
New CMS Policy
Part D Enrollees Guaranteed Stable Formularies
By News Staff
"Formulary stability is extremely important so that enrollees maintain access to the benefit they chose during enrollment as represented to them by the plan," says an April 26 memorandum to Part D plan sponsors. "… Under Part D, no beneficiaries will be subject to a discontinuation or reduction in coverage of the drugs they are currently using, except for clear scientific and cost reasons, including the availability of a new generic version of the drug or new FDA or clinical information."
As a result, Medicare patients are assured of continued coverage for drugs that had been on a plan's formulary when the patient enrolled. The previous policy allowed plans to change their formularies by dropping drugs, changing copayments or instituting utilization management requirements every 30 days. Patients, however, could not change their Part D plans for a year.
To date, CMS has received 4,600 requests from drug plans wanting to change their formularies, said CMS Administrator Mark McClellan, M.D., Ph.D., in an April 26 article in The New York Times. Of that number, about 3,100 involved adding drugs or making small changes, and 1,500 involved significant changes that would be affected by the new policy, which already has gone into effect.
The new policy responds to patient advocates' and lawmakers' concerns about possible "bait-and-switch" ploys, in which Part D plans could promise coverage of a particular drug to potential enrollees but then drop coverage for that drug after patients had signed up for the plan.
"Medicare beneficiaries select Part D plans, in part, based on the formulary that is marketed during annual open enrollment and, therefore, have a legitimate expectation that they will have continuing access to coverage of the Part D drugs they are using throughout the plan year," the memorandum says.
The new policy will be in effect at least through 2006, and CMS "expects that Part D plans will continue to comply with this policy in 2007 and subsequent plan years, and will include such assurances in their future bids and contracts," says the memorandum.
On April 27, Sen. Max Baucus, D-Mont., ranking minority member of the Senate Finance Committee, introduced the Medicare Prescription Drug Simplification Act of 2006, S. 2665, a bill designed to simplify choices, stabilize formularies and increase plan transparency. Among the bills' provisions:
As a result, Medicare patients are assured of continued coverage for drugs that had been on a plan's formulary when the patient enrolled. The previous policy allowed plans to change their formularies by dropping drugs, changing copayments or instituting utilization management requirements every 30 days. Patients, however, could not change their Part D plans for a year.
To date, CMS has received 4,600 requests from drug plans wanting to change their formularies, said CMS Administrator Mark McClellan, M.D., Ph.D., in an April 26 article in The New York Times. Of that number, about 3,100 involved adding drugs or making small changes, and 1,500 involved significant changes that would be affected by the new policy, which already has gone into effect.
The new policy responds to patient advocates' and lawmakers' concerns about possible "bait-and-switch" ploys, in which Part D plans could promise coverage of a particular drug to potential enrollees but then drop coverage for that drug after patients had signed up for the plan.
"Medicare beneficiaries select Part D plans, in part, based on the formulary that is marketed during annual open enrollment and, therefore, have a legitimate expectation that they will have continuing access to coverage of the Part D drugs they are using throughout the plan year," the memorandum says.
The new policy will be in effect at least through 2006, and CMS "expects that Part D plans will continue to comply with this policy in 2007 and subsequent plan years, and will include such assurances in their future bids and contracts," says the memorandum.
On April 27, Sen. Max Baucus, D-Mont., ranking minority member of the Senate Finance Committee, introduced the Medicare Prescription Drug Simplification Act of 2006, S. 2665, a bill designed to simplify choices, stabilize formularies and increase plan transparency. Among the bills' provisions:
- the Secretary of HHS will develop uniform types of benefit packages, with uniform marketing and patient education language, that insurers can begin offering in 2008;
- formularies will be stable, consistent and transparent across all drug plans;
- drug plans cannot remove or limit access to drugs during the plan year except when generic equivalents become available or drugs are deemed unsafe; and
- plans will provide detailed information about their formularies, including cost and use restrictions, in standardized formats so patients can compare plans easily.
More From AAFP
Medicare Prescription Drug Coverage (Medicare Part D)
Medicare Prescription Drug Coverage (Medicare Part D)
Share this on AAFP Connection
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Government & Medicine
PCMH Is Answer to Medicare Payment Problems
Physician Groups Unite to Call for SGR Repeal
Threatened Medicare Payment Cuts Cause Chaos for FPs
AAFP, Medical Organizations Push for SGR Repeal
Focus of Conference Call is Shared Savings, Advance Payment
FPs Can Expect Slight Changes in Medicare Pay for 2012
HHS Approach to Essential Health Benefits Falls Flat
CMS Delays Implementation of 'Sunshine Act'
Congress Works Out Temporary Solution to SGR Cut
Community-based Residencies Would Benefit From House Bill
GME Funding to Remain Level in 2012
House Rejects Measure to Block Medicare Pay Cut
House Addresses Medicare Payment Cut
AAFP Backs Tavenner as New CMS Administrator
Supercommittee Fails to Address SGR
Overcoming Scarce Resources to Enact Health Care Reform
Medicare Payment: Value Is as Important as Volume
AAFP President-elect Makes Return Visit to Capitol Hill
Insurance Exchanges, CO-OPs Might Provide Opportunity for FPs
AAFP Members Speak Out on Title VII Funding
Campaign Addresses Need for Medicare Payment Reform
AAFP Continues to Press Congress for Payment Solution
AAFP Leaders Take On Washington
Campaign Focuses on GME Outreach
'Family Medicine Matters,' AAFP Members Tell Congress
AAFP Outlines Suggested Changes for CO-OP Program
Groups Call on Supercommittee to Address Medical Liability Reform
Grassroots Efforts to Repeal SGR Continue
Bill Linking Mandatory Education to Prescribing Not Needed
Blended Payment Model Gives Boost to Primary Care Services
AAFP Joins AMA, Other Groups in Calling for SGR Repeal
Eliminating SGR May Come With High Price
Tobacco Oversight Must Include Cigars, Say AAFP, Other Groups
AAFP Rallies Congress of Delegates on Medicare Payment
AMA Task Force Focuses on Fixing the SGR
2012 Physician Fee Schedule Needs Work, Says AAFP
New Task Force Takes Steps to Better Value Primary Care
Deficit-reduction Plan Must Eliminate SGR, Says AAFP
Physicians File Lawsuit Over RUC, CMS Relationship
Policy Brief Explains HHS Insurance Exchange Plans